Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir in Black/African American and Hispanic Patients with Chronic HBV
NCT00371150Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 4, open-label, single-arm trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Primary endpoint: Percentage of Participants With HBV DNA < 50 IU/mL at Week 48. Started Nov 2006; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00371150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371150.